CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 360263-360491 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T89315","span":{"begin":0,"end":228},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Our previous studies demonstrated that oligomeric recombinant TCR ligands (RTL) can treat clinical signs of experimental autoimmune encephalomyelitis (EAE) and induce long-term T cell tolerance against encephalitogenic peptides."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T768","span":{"begin":0,"end":228},"obj":"Epistemic_statement"}],"text":"Our previous studies demonstrated that oligomeric recombinant TCR ligands (RTL) can treat clinical signs of experimental autoimmune encephalomyelitis (EAE) and induce long-term T cell tolerance against encephalitogenic peptides."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T216","span":{"begin":0,"end":228},"obj":"Sentence"}],"text":"Our previous studies demonstrated that oligomeric recombinant TCR ligands (RTL) can treat clinical signs of experimental autoimmune encephalomyelitis (EAE) and induce long-term T cell tolerance against encephalitogenic peptides."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T634","span":{"begin":151,"end":154},"obj":"Phenotype"}],"attributes":[{"id":"A634","pred":"hp_id","subj":"T634","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Our previous studies demonstrated that oligomeric recombinant TCR ligands (RTL) can treat clinical signs of experimental autoimmune encephalomyelitis (EAE) and induce long-term T cell tolerance against encephalitogenic peptides."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2195","span":{"begin":108,"end":149},"obj":"Disease"},{"id":"T2196","span":{"begin":132,"end":149},"obj":"Disease"},{"id":"T2197","span":{"begin":151,"end":154},"obj":"Disease"},{"id":"T85555","span":{"begin":108,"end":149},"obj":"Disease"},{"id":"T72646","span":{"begin":132,"end":149},"obj":"Disease"},{"id":"T92366","span":{"begin":151,"end":154},"obj":"Disease"}],"attributes":[{"id":"A2195","pred":"mondo_id","subj":"T2195","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A2196","pred":"mondo_id","subj":"T2196","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A2197","pred":"mondo_id","subj":"T2197","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A2198","pred":"mondo_id","subj":"T2197","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A2199","pred":"mondo_id","subj":"T2197","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A38220","pred":"mondo_id","subj":"T85555","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A95512","pred":"mondo_id","subj":"T72646","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A99814","pred":"mondo_id","subj":"T92366","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A64872","pred":"mondo_id","subj":"T92366","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A37036","pred":"mondo_id","subj":"T92366","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"}],"text":"Our previous studies demonstrated that oligomeric recombinant TCR ligands (RTL) can treat clinical signs of experimental autoimmune encephalomyelitis (EAE) and induce long-term T cell tolerance against encephalitogenic peptides."}